Two-Year-Old Teddy Sloman Travels to US for Specialist Neuroblastoma Cancer Therapy
Two-year-old Teddy Sloman, diagnosed with an aggressive form of neuroblastoma, has departed for New York to receive specialist cancer treatment. His family successfully raised £300,000 through public donations to fund the experimental therapy.
Teddy's parents, from East Leake in Nottinghamshire, confirmed their arrival in the United States, expressing cautious optimism for the upcoming medical procedures. The treatment programme is anticipated to last between 12 and 18 months at the Memorial Sloan Kettering Cancer Centre.
The toddler's diagnosis of high-risk neuroblastoma occurred in November 2022. He subsequently underwent extensive chemotherapy and surgery in the UK. However, the family sought alternative treatment options abroad after being informed by clinicians that further interventions within the NHS were limited to palliative care.
The significant fundraising effort, supported by the national charity Neuroblastoma UK, underscores the difficulties families face in accessing advanced or experimental treatments for rare childhood cancers within the existing healthcare framework. The substantial financial burden often pushes families to seek costly private care overseas.
The family stated that while the journey is long, they are committed to pursuing every avenue for Teddy's recovery, highlighting the challenging choices presented by the limitations of domestic medical provisions for such complex conditions.
